| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46809fed6ea8597aa06eb857ff7f78c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_807038268ea8f141a6328106ab733da6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c4fab1831b1b4e44549233d45fcf0a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395d0e1e8e28422911336dbf54900548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25fbb24042a058ed1bb924054750f546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38bbb1b0c777d1736ac57fac438f3ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f06d5f6939cf387380c56ee1df223ad |
| publicationDate |
2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11434258-B2 |
| titleOfInvention |
Compounds (immunorhelins) |
| abstract |
The present invention provides immune stimulating peptides (immunorhelins) capable of stimulating GnRH receptors when dosed to human patients or cells. These immunorhelins have utility in treating viral diseases and cancer. |
| priorityDate |
2017-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |